greeksoup/ stock research

Cardinal Health (CAH) FY2025 results: revenue $222.6 billion, down 1.9% on the year

Cardinal Health Inc. (CAH) reported revenue of $222.6 billion for fiscal 2025, the year ended 30 June 2025, down 1.9% on the year before. Net income was $1.6 billion, up 83.2%, and diluted earnings per share $6.45. The figures are the company's own, from the 10-K it filed with the SEC on 12 August 2025.

Revenue
$222.6 billion
-1.9% on the year
FY2018FY2025
Operating margin
1.0%
0.5% a year earlier
FY2018FY2025
Net income
$1.6 billion
+83.2% on the year
FY2018FY2025
Diluted EPS
$6.45
+87.0% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025

Income statement (profit and loss)

$ millionFY2025FY2024FY2023On the yearLast 8 years
Revenue222,578226,827205,012-1.9%
Cost of revenue214,410219,413198,123-2.3%
Gross profit8,1687,4146,874+10.2%
Gross margin3.7%3.3%3.4%
Selling, general and administrative5,3825,0004,800+7.6%
Operating income2,2751,243752+83.0%
Operating margin1.0%0.5%0.4%
Interest expense21551.084.0+321.6%
Pre-tax income2,1011,201663+74.9%
Income tax532348332+52.9%
Effective tax rate25.3%29.0%50.1%
Net income1,561852330+83.2%
Net margin0.7%0.4%0.2%
Diluted EPS$6.45$3.45$1.26+87.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2025FY2024FY2023On the yearLast 8 years
Operating cash flow2,3973,7622,839-36.3%
Capital expenditure547511481+7.0%
Free cash flow1,8503,2512,358-43.1%
Free cash flow margin0.8%1.4%1.2%
Cash from investing-5,593-1,849-454
Cash from financing1,940-847-3,051
Depreciation and amortisation790710692+11.3%
Share-based compensation24412196.0+101.7%
Buybacks7657502,000+2.0%
Dividends paid494499525-1.0%
Dividend per share$2.02$2.00$1.98+1.0%
Diluted shares, weighted242m247m262m-2.0%

Balance sheet

$ millionFY2025FY2024FY2023On the yearLast 8 years
Shareholders' equity-2,781-3,213-2,958
Non-controlling interest1471.01.0+14,600.0%
Debt8,5275,1004,700+67.2%
Operating lease liabilities654400375+63.5%
Finance lease liabilities15775.059.0+109.3%
Other liabilities46,41842,75841,240+8.6%
Total liabilities and equity53,12245,12143,417+17.7%
Fixed assets2,8582,5292,462+13.0%
Goodwill9,6914,7254,609+105.1%
Intangible assets2,4861,7251,472+44.1%
Investmentsn/a200n/a
Cash and equivalents3,8745,1334,076-24.5%
Receivables13,24212,08411,108+9.6%
Inventory16,83114,95716,119+12.5%
Other assets4,1403,7683,571+9.9%
Total assets53,12245,12143,417+17.7%

10-K for the year ended 30 June 2025, filed 12 August 2025: the filing.